CONTACTFORIMMEDIATERELEASEQUOTIENTBIODIAGNOSTICS.pdfVIP

CONTACT: Michael Hannan Quotient Biodiagnostics 215-497-8820 michael.hannan@ FOR IMMEDIATE RELEASE QUOTIENT BIODIAGNOSTICS CONDUCTS SUCCESSFUL INDUSTRY WORKSHOP, THE MYTH AND MYSTERY OF RhD AT 2011 AABB ANNUAL MEETING ATTENDEES RATE PROGRAM 3.9 OUT OF 4.0 NEWTOWN, PA (October 24, 2011) Quotient Biodiagnostics, Inc., dedicated to providing high quality immunohematology products to blood banks and hospitals, today hosted an Industry Workshop entitled The Myth and Mystery of RhD at the 2011 Annual Meeting of the AABB. The program consisted of three presentations by an august set of panelists. The panelists were: ? Christine Lomas-Francis, MSc, FIBMS, Technical Director, Immunohematology and Genomics, New York Blood Center, who presented on The Clinical Significance of RhD ? Susan T. Johnson, MSTM, MT(ASCP), SBB Director, Clinical Education BloodCenter of Wisconsin, who presented on Anti-D Reagent Selection Qualification, and ? Joyce Poole, FRC Path, CSci, FIBMS, Reference Manager, International Blood Group Reference Laboratory Bristol, UK, who presented on The Reasons Behind the Myth and Mystery “We are honored to have such a distinguished group of experts presenting on what is obviously an interesting and important subject to the blood banking community, said Michael Hannan, E.V.P., Commercial Operations, Quotient Biodiagnostics. “This is the first workshop Quotient has conducted at AABB, and we are very happy with the caliber and enthusiasm of the presenters, the strength of the educational content, and the high evaluation ratings the program